PLYXPolaryx Therapeutics, Inc.
Earnings
When Polaryx Therapeutics, Inc. reports, what it reported each quarter, and how the stock took the results.
7 quarters. Mar 31, 2025 to Sep 30, 2026. mixed units.
Latest results
- Q3 2026Nov 12, 2026, after the close
- Revenue
- —
- —
- Net income
- -$3.33M
- N/M
- EPS
- -$0.07
- N/M
- Revenue
- —
- —
- Net income
- -$1.38M
- N/M
- EPS
- -$0.03
- N/M
- Revenue
- —
- —
- Net income
- -$2.54M
- N/M
- EPS
- -$0.05
- N/M
- Revenue
- —
- —
- Net income
- -$1.50M
- —
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | — | Nov 12, 2026 | 43 d | 10-Q | — | — | -$0.07 | — | |
| Q2 2026 | Jun 30, 2026 | — | Aug 13, 2026 | 44 d | 10-Q | — | — | -$0.03 | +3.2% | |
| Q1 2026 | Mar 31, 2026 | — | May 15, 2026 | 45 d | 10-Q | — | — | -$0.05 | 21.7% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | — | Mar 24, 2026 | 83 d | 10-K | — | — | — | +16.7% | |
| Q3 2025 | Sep 30, 2025 | — | — | — | — | — | — | -$0.03 | — | |
| Q2 2025 | Jun 30, 2025 | — | — | — | — | — | — | -$0.02 | — | |
| Q1 2025 | Mar 31, 2025 | — | — | — | — | — | — | -$0.11 | — | |
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Polaryx Therapeutics, Inc. · CIK 2075320 · Engraved from SEC EDGAR